‹ All stocks
Parabilis Medicines
PBLS · NASDAQ · Healthcare
$28.63
▼ $28.63 (-5.65%)
Day range
$28.30 – $30.63
Year range
$24.51 – $42.34
Open
$30.34
Previous close
—
Market cap
$3.34B
Volume (24h)
$249.9K
Volume (52w)
$7.15M
Performance
7D
▼ -12.11%
1M
▼ -28.63%
3M
▼ -1.97%
6M
▼ -9.41%
1Y
▼ -9.41%
YTD
▼ -9.41%
3Y
▼ -9.41%
5Y
▼ -9.41%
All-time
▼ -9.41%
Key statistics
P/E ratio
-9.42
EPS (TTM)
$-3.04
Dividend yield
—
Dividend (TTM)
—
Payout ratio
—
Shares outstanding
116.6M
About Parabilis Medicines
Fog Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company. It discovers and develops cell-penetrating miniproteins (CPMPs), which are specifically designed to target cancer-causing proteins inside cancer cells and neutralize them. The company was founded by Gregory L. Verdine, WeiQing Zhou and David Philip Lane in 2015 and is headquartered in Cambridge, MA.
Visit websiteCountry: United States of America
More in Healthcare
LLY Eli Lilly and Company |
$1139.65 | -1.23% |
JNJ Johnson & Johnson |
$256.11 | -1.42% |
ABBV AbbVie |
$260.91 | 0.45% |
MRK Merck & Co. |
$143.38 | -0.27% |
UNH UnitedHealth Group Incorp… |
$368.09 | 0.81% |